Kalvista Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 |
|---|---|---|---|---|
Revenue | $1,426 | $0 | $0 | $0 |
Gross Profit | 836 | 224 | ||
EBITDA | -59,009 | -42,560 | -41,191 | -45,584 |
EBIT | -42,821 | -41,420 | -45,811 | |
Net Income | -60,096 | -52,224 | -48,509 | -42,268 |
Net Change In Cash | 1,426 | 0 | 0 | 0 |
Free Cash Flow | -54,502 | -40,014 | -32,808 | -39,844 |
Cash | 124,304 | 98,644 | 167,288 | 41,581 |
Basic Shares | 53,497 | 49,652 | 52,638 | 46,695 |
Annual Financials
| Values in thousands | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -941 | -86,167 | -802 | -743 |
EBITDA | -173,326 | -134,280 | -92,105 | -81,596 |
EBIT | -174,267 | -135,096 | -92,907 | -82,339 |
Net Income | -183,444 | -126,644 | -74,853 | -68,512 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 24,270 | -18,693 | ||
Free Cash Flow | -152,907 | -89,674 | -76,457 | -79,065 |
Cash | 98,644 | 31,789 | 56,238 | 30,732 |
Basic Shares | 49,652 | 36,786 | 27,890 | 24,473 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-10-31 | $0 |
2025-07-31 | -$1.12 |
2025-04-30 | -$0.99 |
2025-01-31 | -$0.92 |
